Imidazopyrimidine derivatives

US9617266B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Guenter Hoelzemann · Seeheim-Jugenheim, DE
• Dieter Dorsch · Ober-Ramstadt, DE
• Ansgar Wegener · Heusenstamm, DE
• Oliver Poeschke · Wiesbaden, DE
• Michael Busch · Darmstadt, DE
• Jeyaprakashnarayanan Seenisamy · Bengaluru, IN

Key dates

• Filing date: Feb 11, 2014
• Grant date: Apr 11, 2017
• Expiry date: Feb 11, 2034

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula Iin which X, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.